IPO Journey
BIOLARGO, INC.
IPO Date: April 17, 2026 · 6 filings tracked
Final Offer Terms
Ticker
BLGO
Exchange
OTCQX Best Market
Shares Offered
30,000,000
Underwriters
Led by Clearthink Capital Partners, LLC
Filing Timeline
1
424B4
Material Update
April 25, 2025
- Diverse technology portfolio spanning PFAS water remediation, odor control, and antimicrobial wound care.
- Flagship 'CupriDyne Clean' product provides established revenue stream in the waste management sector.
2
424B4
Material Update
June 11, 2025
- Diversified environmental technology portfolio including water treatment, odor control, and air filtration.
- Proprietary AEC system technology specifically designed to remove 'forever chemicals' (PFAS) from water.
Changes from previous filing
- ▸ Shares offered: 34,888,449
3
S-1
April 9, 2026
- Diverse technology portfolio spanning odor control, water treatment, and energy storage
- Proprietary AEC system achieves 99% success rate in removing PFAS 'forever chemicals'
Changes from previous filing
- ▸ Ticker symbol removed
4
S-1
April 9, 2026
- Innovative technology portfolio targeting high-demand sectors like PFAS water remediation.
- Diversified revenue streams including product sales, engineering services, and future licensing royalties.
5
424B4
Material Update
April 17, 2026
- Innovative 'problem-solving lab' model targeting high-demand sectors like PFAS water remediation.
- Diverse portfolio of proprietary technologies, including the Aqueous Electrostatic Concentrator (AEC) and Cellinity™ liquid sodium batteries.
Changes from previous filing
- ▸ Ticker symbol: BLGO
- ▸ Exchange: OTCQX Best Market
- ▸ Shares offered: 31,730,651
424B4
Final Pricing
April 17, 2026
- Diversified technology incubator spanning environmental, medical, and battery sectors.
- Proprietary AEC technology targeting the high-demand PFAS 'forever chemicals' market.
Changes from previous filing
- ▸ Shares offered: 30,000,000
- ▸ Underwriters: Clearthink Capital Partners, LLC
Disclaimer: AI-generated analysis for informational purposes only. Not financial advice. Always conduct your own research.